Glaukos (GKOS) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.92% |
| Dec 31, 2025 | 8.75% |
| Sep 30, 2025 | 1.88% |
| Jun 30, 2025 | 0.57% |
| Mar 31, 2025 | -2.47% |
| Dec 31, 2024 | -18.98% |
| Sep 30, 2024 | 3.98% |
| Jun 30, 2024 | 16.82% |
| Mar 31, 2024 | 23.95% |
| Dec 31, 2023 | 1.09% |
| Sep 30, 2023 | -10.38% |
| Mar 31, 2023 | 12.89% |
| Dec 31, 2022 | -24.17% |
| Sep 30, 2022 | -38.05% |
| Jun 30, 2022 | -36.88% |
| Mar 31, 2022 | -46.64% |
| Dec 31, 2021 | -50.03% |
| Sep 30, 2021 | -0.13% |
| Jun 30, 2021 | -68.02% |
| Mar 31, 2021 | 1.16% |
| Dec 31, 2020 | -57.96% |
| Sep 30, 2020 | -61.25% |
| Mar 31, 2020 | -137.28% |
| Dec 31, 2019 | -112.63% |
| Sep 30, 2019 | -99.38% |
| Jun 30, 2019 | -47.99% |
| Mar 31, 2019 | -47.99% |
| Dec 31, 2018 | -11.40% |
| Sep 30, 2018 | -6.49% |
| Jun 30, 2018 | 37.90% |
| Mar 31, 2018 | -186.86% |
| Dec 31, 2017 | -27.20% |
| Sep 30, 2017 | -107.44% |
| Jun 30, 2017 | -84.87% |
| Dec 31, 2016 | 1.17% |